coenzyme Q10 and L carnitine in Benign prismatic hyperplasia
Phase 3
Recruiting
- Conditions
- Condition 1: Benign prostatic hyperplasia. Condition 2: Lower urinary tract symptoms.
- Registration Number
- IRCT20200623047893N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
50-75 years old
IPSS=8-19
Prostate volume 40-60 cc
Exclusion Criteria
urinary tract infections
severe liver disease
diabetes
recent treatment with 5 alpha reductase
recent treatment with phototherapy
treatment with antiandrogens and antidepressants
neurological bladder
bladder cancer
prostate cancer
Take atorvastatin
blood pressure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in prostate volume. Timepoint: The beginning the study and the end of study. Method of measurement: Sonography.
- Secondary Outcome Measures
Name Time Method IIEF. Timepoint: The beginning and the end of study. Method of measurement: Questionnaire.